The Business Journals

Power 50 Five to Watch: Bruce Culleton, ProKidney

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Less than six months after ...
The Business Journals

ProKidney appoints Dr. Bruce Culleton as executive VP of clinical development and commercialization

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Dr. Culleton brings over two ...
The Business Journals

ProKidney names new CEO, pauses manufacturing but says it has enough cash to get to Q4 2025

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Outgoing CEO Tim Bertram's total ...
Seeking Alpha

ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript

Welcome, everyone, to the next session of the Citi's Biopharma back-to-school Summit. So we are literally back to school, checking up on all the companies. So the next one is it's my pleasure to ...
ksn.com

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

- Brings more than 20 years of academic and industry experience with extensive expertise in kidney disease - WINSTON-SALEM, N.C., July 17, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ...
The Business Journals

ProKidney CEO cites 'significant progress' after regenerative medicine company loses $163M in 2024

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Most of ProKidney's money went ...